Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome

Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome

BackgroundThis study aims to investigate the prognostic significance of transthyretin in newly diagnosed myelodysplastic syndromes (MDS).MethodsThe clinical, laboratory, and follow-up data of 280 newly diagnosed patients with MDS were collected. The relationship between serum transthyretin levels an...

Full description

Bibliographic Details
Main Authors:	Ying Chen, Tingting Niu, Ting Chen, Yue Wu, Duobing Zou, Cong Shi, Ying Wu, Zhaoyi Zhang, Ningning Wu, Yi Zhang, Xiao Yan, Lixia Sheng, Dingfeng Lv, Guifang Ouyang, Xueqin Chen, Qitian Mu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Nutrition
Subjects:	myelodysplastic syndromes transthyretin prognosis IPSS-R IPSS-M
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2023.1125768/full

Similar Items

Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes
by: Cong Shi, et al.
Published: (2022-01-01)

Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes
by: An Wu, et al.
Published: (2021-05-01)

The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes
by: Cong Shi, et al.
Published: (2022-04-01)

MLL-SEPT5 Fusion Transcript in Myelodysplastic Syndrome Patient With t(11;22)(q23;q11)
by: Duobing Zou, et al.
Published: (2021-12-01)

Transient extra copy of Y chromosome without driver mutation after autologous hematopoietic stem cell transplantation for acute myeloid leukemia: a case report and literature review
by: Ying Chen, et al.
Published: (2022-12-01)

Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome
by: Shi C, et al.
Published: (2022-06-01)

Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms
by: Chantana Polprasert, et al.
Published: (2022-12-01)

Hsa_circ_0012152 and Hsa_circ_0001857 Accurately Discriminate Acute Lymphoblastic Leukemia From Acute Myeloid Leukemia
by: Shanshan Guo, et al.
Published: (2020-09-01)

The effect of bladder function on the efficacy of transurethral prostatectomy in patients with benign prostatic hyperplasia: a retrospective, single-center study
by: Jin Li, et al.
Published: (2024-01-01)

Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome
by: Bruno Deltreggia Benites, et al.
Published: (2013-01-01)

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system
by: Vincenzo Accurso, et al.
Published: (2019-03-01)

Effect of triptorelin on lower urinary tract symptoms in Australian prostate cancer patients
by: Woo HH, et al.
Published: (2017-02-01)

Voiding dysfunction in patients with nasal congestion treated with pseudoephedrine: a prospective study
by: Shao IH, et al.
Published: (2016-07-01)

Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validation
by: Paul Windisch, et al.
Published: (2024-02-01)

OUTCOMES ANALYSIS OF TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) AND TRANSURETHRAL VAPORIZATION OF THE PROSTATE (TUVP) IN PATIENT WITH BENIGN PROSTATE HYPERPLASIA: SYSTEMATIC REVIEW
by: Rafael Otniel Kestito, et al.
Published: (2023-05-01)

TREATMENT OF LOWER URINARY TRACT SYMPTOMS CAUSED BY DOUBLE J STENT WITH SOLIFENACIN AND COMBINATION OF TAMSULOSIN PLUS SOLIFENACIN: A COMPARATIVE STUDY
by: Hanan Noor, et al.
Published: (2018-12-01)

PREVALENCE OVERACTIVE BLADDER AT TERTIARY HOSPITAL : A RETROSPECTIVE SINGLE CENTER STUDY
by: Aditya Airlangga, et al.
Published: (2022-09-01)

Efficacy of Tamsulosin in relieving double-J stent-related symptoms: a randomized controlled study
by: DK Thakur, et al.
Published: (2016-07-01)

Tamsulosin in Lowering Double J Related Symptoms
by: Sudeep Raj KC, et al.
Published: (2018-12-01)

The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis
by: Tatic Aurelia, et al.
Published: (2013-09-01)

Distribution of risk factors of ischemic stroke in Chinese young adults and its correlation with prognosis
by: Xiaoke Wu, et al.
Published: (2022-01-01)

Interpetrosal sphingosine-1-phosphate ratio predicting Cushing’s disease tumor laterality and remission after surgery
by: Heng Sun, et al.
Published: (2023-10-01)

Associations Between PSA Levels and Erectile Dysfunction in the Patient with LUTS
by: Huseyin Celik, et al.
Published: (2016-03-01)

The Effective Way in Answering the IPSS: Patients Themselves or with the Physician?
by: Hasan Turgut, et al.
Published: (2021-03-01)

Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia
by: Mélanie Guilhen, et al.
Published: (2018-10-01)

Sleep Quality and Lower Urinary Tract Symptoms Among Patients with Prostatic Diseases
by: Abimbola Oyelekan, et al.
Published: (2020-05-01)

Research progress on classification and prognostic stratification of myelodysplastic syndrome
by: WU Duoer, CHANG Chunkang
Published: (2023-10-01)

Testosterone treatment and change of categories of the International prostate symptom score (IPSS) in hypogonadal patients: 12 years prospective controlled registry study
by: Aksam Yassin, et al.
Published: (2023-12-01)

Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia
by: Ahmed Radwan, et al.
Published: (2020-09-01)

The effect on the sensitivities of PSA and PSA-age volume score of IPSS and nocturia in predicting positive prostate biopsy findings
by: O. Üçer, et al.
Published: (2017-06-01)

Prevalence of clinical benign prostatic hyperplasia amongst community-dwelling men in a South-Western Nigerian rural setting: A cross-sectional study
by: R.W. Ojewola, et al.
Published: (2017-06-01)

Distal end of Double-J ureteral stent position on ureteral stent-related symptoms: A systematic review and meta-analysis
by: Xingjun Bao, et al.
Published: (2022-08-01)

Impact of age on the Quadrella index assessing oncological and functional results after prostate brachytherapy: A 6-year analysis
by: Guillaume Tremblay, et al.
Published: (2023-04-01)

Impact of Chronic Constipation on Lower Urinary Tract Symptoms and Uroflowmetry Parameters in Men
by: Tarık Yonguç, et al.
Published: (2019-12-01)

Prevalence of lower urinary tract symptoms in patients of benign prostatic hyperplasia attending Tertiary Care Hospital in the State of Andhra Pradesh
by: M Nagarathnam, et al.
Published: (2017-01-01)

Multiparametric MRI may Help to Identify Patients With Prostate Cancer in a Contemporary Cohort of Patients With Clinical Bladder Outlet Obstruction Scheduled for Holmium Laser Enucleation of the Prostate (HoLEP)
by: Mike Wenzel, et al.
Published: (2021-02-01)

The role of Tamsulosin in the treatment of ureteral stent related symptoms in Basrah General Hospital
by: Firas Attar, et al.
Published: (2019-12-01)

COMPARISON OF SOLIFENACIN VERSUS COMBINATION OF SOLIFENACIN AND TAMSULOSIN IN IMPROVING UNILATERAL DOUBLE-J STENT RELATED LOWER URINARY TRACT SYMPTOMS - A PROSPECTIVE RANDOMIZED CONTROL TRIAL
by: Muhammad Tanveer Sajid, et al.
Published: (2021-02-01)

Relationship between visual prostate score (VPSS) and maximum flow rate (Qmax) in men with urinary tract symptoms
by: Mazhar A. Memon, et al.
Published: (2016-04-01)

Efficacy and safety of doxazosin (Cardura TM ) in the management of Benign Prostatic Hyperplasia
by: E A Jeje, et al.
Published: (2011-01-01)